TAUW carried out a comprehensive Climate Risk Assessment in accordance with ISO 14091:2021 for an operational pharmaceutical manufacturing plant in Italy. The facility is dedicated to the production of contrast agents for diagnostic imaging and operates in a highly regulated industrial environment.
The assessment addressed both physical climate risks and transition risks, supporting regulatory compliance and long‑term operational resilience.
Key challenges included the availability and quality of climate data and the complexity of translating climate scenarios into site‑specific operational risks. In addition, the client required insight into the site’s adaptive capacity, which depended strongly on the engagement of management and technical staff.
Beyond physical hazards, the project also needed to address transition risks, such as regulatory changes, technological innovation and market developments relevant to the pharmaceutical sector.
TAUW applied an ISO‑compliant methodology combining climate science and operational analysis:
This integrated approach ensured both compliance and strategic relevance.
The Climate Risk Assessment delivered:
These results enable proactive risk management and informed long‑term decision‑making.
By combining international standards with deep sector expertise, TAUW supported the client in strengthening climate resilience while meeting regulatory and sustainability objectives.
Please get in contact with one of our consultants
